Sangbum Choi, Ph.D
Sangbum Choi, Ph.D
Professor, Department of Statistics, Korea University
Потвърден имейл адрес: korea.ac.kr - Начална страница
Targeted Correction and Restored Function of the CFTR Gene in Cystic Fibrosis Induced Pluripotent Stem Cells
AM Crane, P Kramer, JH Bui, WJ Chung, XS Li, ML Gonzalez-Garay, ...
Stem Cell Reports 4 (4), 569-577, 2015
VcR‐CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study
JE Chang, C Peterson, S Choi, JC Eickhoff, KM Kim, DT Yang, LA Gilbert, ...
British Journal of Haematology 155 (2), 190-197, 2011
Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients≤ 60 years with newly diagnosed acute myeloid leukemia
A Nazha, H Kantarjian, F Ravandi, X Huang, S Choi, G Garcia‐Manero, ...
American Journal of Hematology 88 (11), 961-966, 2013
Early fibrinolysis associated with hemorrhagic progression following traumatic brain injury
J Karri, JC Cardenas, N Matijevic, YW Wang, S Choi, L Zhu, BA Cotton, ...
Shock 48 (6), 644-650, 2017
Optimization of multi‐stage dynamic treatment regimes utilizing accumulated data
X Huang, S Choi, L Wang, PF Thall
Statistics in Medicine, 2015
A two‐stage approach for dynamic prediction of time‐to‐event distributions
X Huang, F Yan, J Ning, Z Feng, S Choi, J Cortes
Statistics in medicine 35 (13), 2167-2182, 2016
Maximum likelihood estimation of semiparametric mixture component models for competing risks data
S Choi, X Huang
Biometrics 70 (3), 588-598, 2014
Sleep duration and mortality in Korean adults: a population-based prospective cohort study
S Kwon, H Lee, JT Lee, MJ Shin, S Choi, H Oh
BMC Public Health 20, 1-10, 2020
Acute myeloid leukemia after myelodysplastic syndrome and failure of therapy with hypomethylating agents: an emerging entity with a poor prognosis
E Jabbour, H Ghanem, X Huang, F Ravandi, G Garcia-Manero, S O'brien, ...
Clinical Lymphoma Myeloma and Leukemia 14 (2), 93-97, 2014
Predicting outcomes in patients with chronic myeloid leukemia at any time during tyrosine kinase inhibitor therapy
A Quintás-Cardama, S Choi, H Kantarjian, E Jabbour, X Huang, J Cortes
Clinical Lymphoma Myeloma and Leukemia 14 (4), 327-334. e8, 2014
Effect of in‐painting on cortical thickness measurements in multiple sclerosis: A large cohort study
KA Govindarajan, S Datta, KM Hasan, S Choi, MH Rahbar, SS Cofield, ...
Human Brain Mapping 36 (10), 3749-3760, 2015
Accelerated failure time models for the analysis of competing risks
S Choi, H Cho
Journal of the Korean Statistical Society 48, 315-326, 2019
Semiparametric accelerated failure time cure rate mixture models with competing risks
S Choi, L Zhu, X Huang
Statistics in medicine 37 (1), 48-59, 2018
A general class of semiparametric transformation frailty models for nonproportional hazards survival data
S Choi, X Huang
Biometrics 68 (4), 1126-1135, 2012
Efficient semiparametric mixture inferences on cure rate models for competing risks
S Choi, X Huang, JN Cormier
The Canadian Journal of Statistics 43 (3), 420-435, 2015
Clinical and bacteriological efficacy of twice daily topical retapamulin ointment 1% in the management of impetigo and other uncomplicated superficial skin infections
BR Bohaty, S Choi, C Cai, AA Hebert
International Journal of Women's Dermatology 1 (1), 13-20, 2015
A semiparametric inverse‐Gaussian model and inference for survival data with a cured proportion
S Choi, X Huang, JN Cormier, KA Doksum
The Canadian Journal of Statistics 42 (4), 635-649, 2014
Association of long-term exposure to PM2. 5 and survival following ischemic heart disease
J Oh, S Choi, C Han, DW Lee, E Ha, S Kim, HJ Bae, WB Pyun, YC Hong, ...
Environmental Research 216, 114440, 2023
A class of semiparametric transformation models for survival data with a cured proportion
S Choi, X Huang, YH Chen
Lifetime Data Analysis 20 (3), 369-386, 2014
Smoothed quantile regression analysis of competing risks
S Choi, S Kang, X Huang
Biometrical Journal 60 (5), 934-946, 2018
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20